Connection

Sarah Buchan to Ontario

Back to Details
This is a "connection" page, showing publications Sarah Buchan has written about Ontario.
Sarah Buchan
Connection Strength
0.985
Ontario
  1. Characteristics Associated With Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Ontario, Canada: A Cohort Study. Clin Infect Dis. 2021 11 16; 73(10):1840-1848.
    View in: PubMed
    Score: 0.142
  2. Association of Age and Pediatric Household Transmission of SARS-CoV-2 Infection. JAMA Pediatr. 2021 11 01; 175(11):1151-1158.
    View in: PubMed
    Score: 0.141
  3. COVID-19 Workplace Outbreaks by Industry Sector and Their Associated Household Transmission, Ontario, Canada, January to June, 2020. J Occup Environ Med. 2021 07 01; 63(7):574-580.
    View in: PubMed
    Score: 0.138
  4. Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002-2016. Clin Infect Dis. 2020 06 24; 71(1):22-29.
    View in: PubMed
    Score: 0.128
  5. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada. PLoS One. 2017; 12(11):e0187834.
    View in: PubMed
    Score: 0.107
  6. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study. BMJ. 2021 08 20; 374:n1943.
    View in: PubMed
    Score: 0.035
  7. Trends in Interregional Travel to Shopping Malls and Restaurants Before and After Differential COVID-19 Restrictions in the Greater Toronto Area. JAMA Netw Open. 2021 08 02; 4(8):e2123139.
    View in: PubMed
    Score: 0.035
  8. Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments. Vaccine. 2021 08 31; 39(37):5265-5270.
    View in: PubMed
    Score: 0.035
  9. S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021. JAMA. 2021 05 25; 325(20):2115-2116.
    View in: PubMed
    Score: 0.034
  10. Variation in Care of Community and Nursing Home Residents Who Died of COVID-19 in Ontario, Canada. J Am Med Dir Assoc. 2021 Jun; 22(6):1149-1150.
    View in: PubMed
    Score: 0.034
  11. Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada. Viruses. 2021 Jan 18; 13(1).
    View in: PubMed
    Score: 0.033
  12. Epidemiology, clinical characteristics, household transmission, and lethality of severe acute respiratory syndrome coronavirus-2 infection among healthcare workers in Ontario, Canada. PLoS One. 2020; 15(12):e0244477.
    View in: PubMed
    Score: 0.033
  13. Influenza Vaccine Effectiveness Among Patients With Cancer: A Population-Based Study Using Health Administrative and Laboratory Testing Data From Ontario, Canada. J Clin Oncol. 2019 10 20; 37(30):2795-2804.
    View in: PubMed
    Score: 0.030
  14. Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort. Vaccine. 2019 07 18; 37(31):4392-4400.
    View in: PubMed
    Score: 0.030
  15. Characteristics of immunized and un-immunized students, including non-medical exemptions, in Ontario, Canada: 2016-2017 school year. Vaccine. 2019 05 21; 37(23):3123-3132.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.